Biotechnology Stocks II Performance Guide: Aerovate Therapeutics, Inc. (AVTE)
AVTE has no dividends.
Table and Chart of AVTE Performance
See what a $1,000 investment in AVTE is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| AVTE Returns | |
|---|---|
| Start Date | Jul-30-2021 |
| Start Price | $12.85 |
| End Date | May-17-2024 |
| End Price | $20.57 |
| # Prices | 35 |
| Min Date | Feb-28-2022 |
| Min Price | $9.78 |
| Max Date | Mar-28-2024 |
| Max Price | $29.57 |
| Total Return | 60.08% |
| Annualized Return | 17.51% |
| Current Value of $1,000 Purchase | $1,601 |
| Number Returns | 595 |
| Average Return | 21.62% |
| Number Profitable Returns | 379 |
| Percent Profitable Returns | 63.70% |
| Number Unprofitable Returns | 216 |
| Percent Unprofitable Returns | 36.30% |
| Profitable to Unprofitable Returns Ratio | 1.75 |
| AVTE Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $631,190,000 |
| Beta | 1.393 | Price to Sales |
| Earnings per Share | $-3.0300 |
| PE Ratio | None |
| PE to Growth Ratio | None |
| Price to Book | 6.43 |
| PRICE DATA | |
| 52 Week High | $32.41 |
| 52 Week Low | $9.41 |
| Analyst Target Price | $44.67 |
| 50-Day Moving Average | $24.16 |
| 200-Day Moving Average | $18.26 |
| FINANCIAL DATA | |
| Revenue per Share | $0 |
| Revenue | $0 |
| Profit Margin | 0% |
| Return on Equity | -80.6% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
AVTE Compare Returns with S&P 500
AVTE Trendline Chart
AVTE Moving Average Chart
AVTE Stock Return Map - See Patterns of Gains and Losses
AVTE Stock Returns/Purchase Dates